Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects
C. Jaeger et al., Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects, DIABET CARE, 24(1), 2001, pp. 27-32
OBJECTIVE - In type 1 diabetes the coexistence with other endocrine disease
s and organ-specific autoantibodies has been frequently reported leading to
the concept of autoimmune polyendocrine syndrome (APS). In addition, an as
sociation of type 1 diabetes with celiac disease has been described. These
disorders share a similar genetic background, and first-degree relatives of
type 1 diabetic patients may also be affected significantly Screening for
specific antibodies allows early diagnosis of these disorders.
RESEARCH DESIGN AND METHODS - In the present cross-sectional study, we anal
yzed sera from 197 recent-onset type 1 diabetic patients at the time of dia
gnosis, 882 first-degree relatives, and sera of 150 healthy control subject
s for prevalence and co-occurence of the following antibodies (method): ins
ulin autoantibodies (radioimmunoassay); GAD and IA-2 antibodies (radioligan
d assay); islet cell antibody anti-adrenal cortex antibodies, and anti-gast
ric parietal cell antibodies (indirect immunofluorescence); anti-thyroglobu
lin and anti-thyroid peroxidase antibodies; and gliadin IgG/A and tissue-tr
ansglutaminase IgA (enzyme-linked immunosorbent assay).
RESULTS - The overall frequency of gastric patietal cell antibodies and adr
enal antibodies did not differ significantly among groups. In contrast, typ
e 1 diabetes-associated antibodies and thyroid antibodies were significantl
y more frequent both in recent-onset type 1 diabetic patients and in the gr
oup of first-degree relatives (P < 0.05). The prevalence of gliadin IgG/IgA
and transglutaminase IgA was significantly higher in the group of recent-o
nset type 1 diabetic patients (P < 0.05), but the difference between first-
degree relatives and control subjects did not reach statistical significanc
e. Focusing on the coexistence of antibodies, the group of recent-onset typ
e 1 diabetic patients presented with 27.4% of the subjects testing antibody
-positive-specific for two or more of the envisaged disorders (i.e., type 1
diabetes, autoimmune thyroiditis, and celiac disease) compared with 3.1% i
n the group of first-degree relatives and 0 of 150 in the control populatio
n (P < 0.05).
CONCLUSIONS - We conclude that, in an active case-finding strategy, recent-
onset type 1 diabetic patients should be routinely screened at least for co
ncomitant autoimmune thyroid disease and additionally for celiac disease. S
creening in their first-degree relatives should include at a minimum the se
arch for thyroid autoimmunity in addition to screening for pre-type 1 diabe
tes.